HKUMed-Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses
June 25, 2026
June 25, 2026
HONG KONG, June 25 -- The University of Hong Kong issued the following news release:
* * *
HKUMed-Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses
*
The on-going evolution of SARS-CoV-2, particularly the rapid emergence of the Omicron variant and its sub-lineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of . . .
* * *
HKUMed-Tsinghua team develops first-in-class broad-spectrum small-molecule antiviral to combat SARS-CoV-2 and related coronaviruses
*
The on-going evolution of SARS-CoV-2, particularly the rapid emergence of the Omicron variant and its sub-lineages, has weakened the effectiveness of existing vaccines and antiviral drugs, underscoring the potential risk of . . .